oncgnostics GmbH is a spin-off of the University women’s hospital Jena, Germany.
oncgnostics was founded in 02.2012. A EU joint project (INCA – Infections and Cancer) with research concerning epigenetic changes during cervical carcinogenesis at the functional unit “Gynecologic Molecular Biology” provided the basis for the spin-off. A subsequent EXIST research transfer project funded by the BMWi enabled the preparation of the foundation.
Research and development as well as the management are certified according to ISO 9001 and ISO 13485 since early 2013.